Company intelligence / Profile preview

WefernLife

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

WefernLife is a biotechnology and wellness company focused on the development and commercialization of longevity-enhancing supplements and metabolic health products. The company specializes in utilizing bioactive compounds, such as NMN (Nicotinamide Mononucleotide) and other cellular health boosters, to address age-related physiological decline. WefernLife positions itself at the intersection of life sciences and consumer health, providing evidence-based formulations designed to optimize mitochondrial function and overall vitality. Their product portfolio is primarily marketed toward consumers seeking proactive management of the aging process and metabolic optimization.

Therapeutic areas: OtherMetabolic Disorders
Modalities: Small moleculePeptides
Industry: Food & Nutrition

Beyond the preview

Go deeper on WefernLife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WefernLife.

Explore the full profile